Financial Ratios

ZIM LABORATORIES LTD.

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC
BSE92.44-3.04 (-3.18 %)
PREV CLOSE ( ) 95.48
OPEN PRICE ( ) 95.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17837
TODAY'S LOW / HIGH ( )91.60 95.95
52 WK LOW / HIGH ( )74 151.75
NSE92.45-3.05 (-3.19 %)
PREV CLOSE( ) 95.50
OPEN PRICE ( ) 95.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 92.45 (7701)
VOLUME 292348
TODAY'S LOW / HIGH( ) 91.85 96.45
52 WK LOW / HIGH ( )73.95 152.7
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)5.138.013.461.089.93
   CEPS(Rs)8.445.724.153.095.61
   DPS(Rs)0.000.000.000.000.50
   Book NAV/Share(Rs)39.85104.7396.6993.5793.05
   Tax Rate(%)30.3732.5634.54217.0229.59
Margin Ratios
   Core EBITDA Margin(%)12.9111.5112.127.2112.79
   EBIT Margin(%)10.468.386.414.0710.05
   Pre Tax Margin(%)9.065.862.83-0.546.85
   PAT Margin (%)6.313.951.850.634.83
   Cash Profit Margin (%)10.378.456.665.478.19
Performance Ratios
   ROA(%)7.383.981.770.545.18
   ROE(%)13.737.963.641.1611.22
   ROCE(%)17.4812.028.124.7514.96
   Asset Turnover(x)1.171.010.960.861.07
   Sales/Fixed Asset(x)2.171.981.941.942.73
   Working Capital/Sales(x)5.805.967.278.268.34
Efficiency Ratios
   Fixed Capital/Sales(x)0.460.510.510.520.37
   Receivable days77.9080.2276.51102.2898.33
   Inventory Days59.3771.8066.5674.1458.65
   Payable days129.58167.28150.70175.78158.14
Valuation Parameters
   PER(x)14.116.656.9917.344.20
   PCE(x)8.589.325.826.037.43
   Price/Book(x)1.821.530.750.601.35
   Yield(%)0.000.000.000.000.40
   EV/Net Sales(x)1.030.940.630.650.83
   EV/Core EBITDA(x)7.117.274.867.276.21
   EV/EBIT(x)9.8811.189.8115.908.29
   EV/CE(x)1.200.920.600.560.85
   M Cap / Sales0.890.790.390.330.61
Growth Ratio
   Net Sales Growth(%)20.358.5210.68-17.3022.00
   Core EBITDA Growth(%)35.778.1060.65-45.0518.96
   EBIT Growth(%)50.3241.8074.31-66.49-0.38
   PAT Growth(%)92.19131.70222.66-89.13-12.46
   EPS Growth(%)-35.94131.71221.45-89.17-56.23
Financial Stability Ratios
   Total Debt/Equity(x)0.310.300.520.590.51
   Current Ratio(x)1.621.381.301.231.26
   Quick Ratio(x)1.130.860.910.840.90
   Interest Cover(x)7.443.321.790.883.15
   Total Debt/Mcap(x)0.170.200.690.990.38

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.